Karen Prange Insider Profile

11 Followers
Karen Prange, SVP&Pres, Uro & Pelvic Health at Boston Scientific, holds 33.95K shares in Nevro Corp (Ticker: NVRO), holds 23.93K shares in Atricure (Ticker: ATRC), holds 24.90K shares in Embecta Corporation (Ticker: EMBC).
tipranks
Karen Prange

Karen Prange
Boston Scientific (BSX)
SVP&Pres, Uro & Pelvic Health

Ranked #76,338 out of 99,218 Corporate Insiders

Profitable Transactions

33%
1 out of 3 Profitable Transactions

Average Return

-25.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$10M
43.96%
42.98%
7.79%
3.45%
1.82% Others
A breakdown of Karen Prange's holdings

Insider Roles

Boston Scientific
(BSX)
SVP&Pres, Uro & Pelvic Health
Henry Schein
(HSIC)
EVP&CEO Gl.AH.Med.Den.Sur.Grp
Atricure
(ATRC)
Director
Embecta Corporation
(EMBC)
Director
+2 other positions
Roles that Karen Prange holds in companies

Most Profitable Insider Trade

Stock:
Atricure
(ATRC)
Rating:Informative Sell
Date:Jun 12, 2023 - Jun 12, 2024
Return:+53.20%
The most profitable trade made by Karen Prange

Karen Prange's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Boston Scientific
Mar 08, 2016
SVP&Pres, Uro & Pelvic Health
Uninformative Sell
254.68K
$4.53M
Henry Schein
Mar 06, 2018
EVP&CEO Gl.AH.Med.Den.Sur.Grp
Uninformative Buy
$4.43M
Atricure
May 14, 2024
Director
Uninformative Buy
$801.83K
Nevro Corp
May 28, 2024
Director
Uninformative Buy
$187.73K
CMD
Cantel Medical
Jul 31, 2020
Uninformative Buy
$155.52K
Viewray
Jul 21, 2023
Director
Informative Sell
8.31K
$105.59
Embecta Corporation
Feb 09, 2024
Director
Uninformative Buy
$354.78K
List of latest transactions for each holding click on a transaction to see Karen Prange's performance on stock

Karen Prange insider profile FAQ

What is the percentage of profitable transactions made by Karen Prange?
The percentage of profitable transactions made by Karen Prange is 33%.
    What is the average return per transaction made by Karen Prange?
    The average return per transaction made by Karen Prange is -25.80%.
      What stocks does Karen Prange hold?
      Karen Prange holds: BSX, HSIC, ATRC, NVRO, CMD, VRAYQ, EMBC stocks.
        What was Karen Prange’s latest transaction?
        Karen Prange latest transaction was an Uninformative Buy of ―.
          What was Karen Prange's most profitable transaction?
          Karen Prange’s most profitable transaction was an Informative Sell of ATRC stock on June 12, 2023. The return on the trade was 53.20%.
            What is Karen Prange's role in Boston Scientific?
            Karen Prange's role in Boston Scientific is SVP&Pres, Uro & Pelvic Health.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.